Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1984-07-20
1986-10-21
Rosen, Sam
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424 88, 424 89, 424 92, 424 85, 424 86, 424 87, 435 2, A61K 3514
Patent
active
046184945
ABSTRACT:
Type 1 Diabetes and other virus-induced or autoimmunological diseases are treated with Human Immune Factors. These Human Immune Factors are extracted from blood cells by activating said blood cells with human lymphoblastoid interferon-alpha or staphage lysate or other activator or combination of activators. Human Immune Factors are purified and made suitable for pharmaceutical use by isolating compounds with molecular weights between about 1,000 and about 25,000 daltons.
REFERENCES:
patent: 4085204 (1978-04-01), Wacker et al.
patent: 4132776 (1979-01-01), Jeter
patent: 4468379 (1984-08-01), Gottlieb
Stiller et al., "Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset", Science, vol. 223, pp. 1362-1367, (Mar. 1984).
Duffy, Vaccine Preparation Techniques, (1980), pp. 281-287.
Induction of Tuberculin Type Hypersensitivity (Self Plus X), Hypothesis.
Lawrence, Recent Advances in the Immunotherapy of Infectious Diseases with Transfer Factor.
Immunology Development Corporation
Rosen Sam
LandOfFree
Human Immune Factors and processes for their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human Immune Factors and processes for their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human Immune Factors and processes for their production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1289136